{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T16:38:19Z","timestamp":1721234299373},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,8]]},"abstract":"Abstract<\/jats:title>\n \n Purpose<\/jats:title>\n To describe a community hospital pharmacy department\u2019s novel approach to addressing safe use of fentanyl patches in acute and subacute care patients.<\/jats:p>\n <\/jats:sec>\n \n Summary<\/jats:title>\n Beginning in 2017, improvement opportunities were identified within the medication-use process for fentanyl patches at Cleveland Clinic Euclid Hospital. Prescribing was addressed through development of a procedure requiring an opioid status verification by a pharmacist for all fentanyl patch orders. This procedure includes determination of indication, review of prior opioid use, and documentation within the medical record. At baseline in 2017, 11 of 45 fentanyl patches were initiated for acute pain. In the first year of the procedure, 1 of 13 orders was initiated for acute pain, and in the second year 2 of 24 orders for fentanyl patches were initiated for acute pain. With each review, the pharmacy department identified additional safety and clinical education opportunities. Subsequently, inventory and dispensing practices for patches were assessed. The hospital\u2019s inventory was decreased and dispensing practices were altered to mitigate accessibility of the patches. This resulted in a decrease of 73.65% in the on-hand quantity from 2018 to 2020. The overall morphine milligram equivalents (MME) per 24 hours of this dosage form available in the hospital were reduced from 56,073.6 MME in 2018 to 13,557.6 MME in 2020 (75.82% decrease).<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Evaluation of the fentanyl patch medication-use process and pharmacy-driven interventions resulted in an increase in appropriate utilization of fentanyl patches and a decrease in accessible MME of this potent dosage form.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/ajhp\/zxab409","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T17:24:37Z","timestamp":1635787477000},"page":"290-296","source":"Crossref","is-referenced-by-count":1,"title":["Optimization of the medication-use process for fentanyl patches at a small community hospital"],"prefix":"10.1093","volume":"79","author":[{"given":"Patricia","family":"Roberts","sequence":"first","affiliation":[{"name":"University Hospitals Cleveland Medical Center, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Glowczewski","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Fairview Hospital, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Wise","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Euclid Hospital, Euclid, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"2022020903571551000_CIT0001","author":"Centers for Disease Control and Prevention"},{"key":"2022020903571551000_CIT0002","author":"Centers for Disease Control and Prevention"},{"issue":"RR-1","key":"2022020903571551000_CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep."},{"key":"2022020903571551000_CIT0004","author":"Food and Drug Administration"},{"key":"2022020903571551000_CIT0005","volume-title":"R3 report: pain assessment and management standards for hospitals","author":"Joint Commission","year":"2017"},{"key":"2022020903571551000_CIT0006","author":"Food and Drug Administration"},{"issue":"4","key":"2022020903571551000_CIT0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF03178274","article-title":"Transdermal fentanyl: pharmacology and toxicology","volume":"5","author":"Nelson","year":"2009","journal-title":"J Med Toxicol"},{"key":"2022020903571551000_CIT0008","author":"Food and Drug Administration"},{"issue":"10","key":"2022020903571551000_CIT0009","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1093\/pm\/pnaa091","article-title":"Initiation of transdermal fentanyl among US commercially insured patients between 2007 and 2015","volume":"21","author":"Costantino","year":"2020","journal-title":"Pain Med"},{"issue":"2","key":"2022020903571551000_CIT0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamda.2016.08.015","article-title":"Inappropriate fentanyl prescribing among nursing home residents in the United States","volume":"18","author":"Fain","year":"2017","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"2022020903571551000_CIT0011","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1310\/hpj4910-942","article-title":"Inpatient prescribing and monitoring of fentanyl transdermal systems: adherence to safety regulations","volume":"49","author":"McEvoy","year":"2014","journal-title":"Hosp Pharm"},{"key":"2022020903571551000_CIT0012","author":"Institute for Safe Medication Practices"},{"key":"2022020903571551000_CIT0013","volume-title":"ISMP 2018-2019 Targeted Medication Safety Best Practices for Hospitals","author":"Institute for Safe Medication Practices","year":"2018"},{"key":"2022020903571551000_CIT0014","article-title":"Quality improvement and the medication use system.","volume-title":"Drug Information: A Guide for Pharmacists","author":"Thomas","edition":"6th ed"},{"key":"2022020903571551000_CIT0015","article-title":"Managing technology that supports the medication use process.","volume-title":"Pharmacy Management: Essentials for All Practice Settings","author":"Fox","edition":"5th ed"},{"key":"2022020903571551000_CIT0016","volume-title":"ISMP 2020-2021 Targeted Medication Safety Best Practices for Hospitals","author":"Institute for Safe Medication Practices","year":"2020"},{"key":"2022020903571551000_CIT0017","author":"Institute for Safe Medication Practices","year":"2020"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxab409\/41036537\/zxab409.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/79\/4\/290\/42431916\/zxab409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/79\/4\/290\/42431916\/zxab409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T04:01:31Z","timestamp":1644379291000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/79\/4\/290\/6415252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2022,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxab409","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,15]]},"published":{"date-parts":[[2021,11,1]]}}}